509 related articles for article (PubMed ID: 12797461)
1. Guidelines for case classification for the National Birth Defects Prevention Study.
Rasmussen SA; Olney RS; Holmes LB; Lin AE; Keppler-Noreuil KM; Moore CA;
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):193-201. PubMed ID: 12797461
[TBL] [Abstract][Full Text] [Related]
2. Integration of DNA sample collection into a multi-site birth defects case-control study.
Rasmussen SA; Lammer EJ; Shaw GM; Finnell RH; McGehee RE; Gallagher M; Romitti PA; Murray JC;
Teratology; 2002 Oct; 66(4):177-84. PubMed ID: 12353214
[TBL] [Abstract][Full Text] [Related]
3. Clinician reviewers in birth defects surveillance programs: survey of the National Birth Defects Prevention Network.
Lin AE; Forrester MB; Cunniff C; Higgins CA; Anderka M
Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):781-6. PubMed ID: 17051528
[TBL] [Abstract][Full Text] [Related]
4. Prepregnancy obesity as a risk factor for structural birth defects.
Waller DK; Shaw GM; Rasmussen SA; Hobbs CA; Canfield MA; Siega-Riz AM; Gallaway MS; Correa A;
Arch Pediatr Adolesc Med; 2007 Aug; 161(8):745-50. PubMed ID: 17679655
[TBL] [Abstract][Full Text] [Related]
5. Population and case-control surveillance in the search for environmental causes of birth defects.
Oakley GP
Public Health Rep; 1984; 99(5):465-8. PubMed ID: 6207556
[TBL] [Abstract][Full Text] [Related]
6. Clinical geneticists in birth defects surveillance and epidemiology research programs: past, present and future roles.
Lin AE; Rasmussen SA; Scheuerle A; Stevenson RE
Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):69-75. PubMed ID: 19107957
[TBL] [Abstract][Full Text] [Related]
7. Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth Defects Prevention Study.
Slickers JE; Olshan AF; Siega-Riz AM; Honein MA; Aylsworth AS;
Am J Epidemiol; 2008 Dec; 168(11):1259-67. PubMed ID: 18835865
[TBL] [Abstract][Full Text] [Related]
8. Birth Defects Cluster Study: a national approach to birth defects cluster investigations.
Kucik JE; Bitsko RH; Williams L; Lazarus C; Jarman DW; Correa A
Birth Defects Res A Clin Mol Teratol; 2008 Nov; 82(11):805-11. PubMed ID: 18985695
[TBL] [Abstract][Full Text] [Related]
9. Maternal smoking and congenital heart defects.
Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
[TBL] [Abstract][Full Text] [Related]
10. Ethical issues raised by incorporation of genetics into the National Birth Defects Prevention Study.
Jenkins MM; Rasmussen SA; Moore CA; Honein MA
Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):40-6. PubMed ID: 18189287
[TBL] [Abstract][Full Text] [Related]
11. Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).
Tinker SC; Carmichael SL; Anderka M; Browne ML; Caspers Conway KM; Meyer RE; Nembhard WN; Olney RS; Reefhuis J;
Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):733-40. PubMed ID: 25846741
[TBL] [Abstract][Full Text] [Related]
12. Interaction between epidemiology and laboratory sciences in the study of birth defects: design of birth defects risk factor surveillance in metropolitan Atlanta.
Lynberg MC; Khoury MJ
J Toxicol Environ Health; 1993; 40(2-3):435-44. PubMed ID: 8230314
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for birth defects: data from the Atlanta Birth Defects Case-Control Study.
Erickson JD
Teratology; 1991 Jan; 43(1):41-51. PubMed ID: 2006471
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of selected characteristics of pregnancy drug registries.
Honein MA; Paulozzi LJ; Cragan JD; Correa A
Teratology; 1999 Dec; 60(6):356-64. PubMed ID: 10590397
[TBL] [Abstract][Full Text] [Related]
15. Preventing birth defects: The value of the NBDPS case-control approach.
Dolk H
Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):670-9. PubMed ID: 26172859
[TBL] [Abstract][Full Text] [Related]
16. The National Congenital Anomalies Register in the United Arab Emirates.
Al Hosani H; Salah M; Abu-Zeid H; Farag HM; Saade D
East Mediterr Health J; 2005 Jul; 11(4):690-9. PubMed ID: 16700385
[TBL] [Abstract][Full Text] [Related]
17. Using the Hungarian Birth Defects Registry for surveillance, research and intervention.
Siffel C; Czeizel AE
Cent Eur J Public Health; 1997 Jun; 5(2):79-81. PubMed ID: 9208163
[TBL] [Abstract][Full Text] [Related]
18. Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program.
Riehle-Colarusso T; Strickland MJ; Reller MD; Mahle WT; Botto LD; Siffel C; Atkinson M; Correa A
Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):743-53. PubMed ID: 17990334
[TBL] [Abstract][Full Text] [Related]
19. The National Birth Defects Prevention Study.
Yoon PW; Rasmussen SA; Lynberg MC; Moore CA; Anderka M; Carmichael SL; Costa P; Druschel C; Hobbs CA; Romitti PA; Langlois PH; Edmonds LD
Public Health Rep; 2001; 116 Suppl 1(Suppl 1):32-40. PubMed ID: 11889273
[TBL] [Abstract][Full Text] [Related]
20. Demographic and environmental risk factors for gastroschisis and omphalocele in the National Birth Defects Prevention Study.
Mac Bird T; Robbins JM; Druschel C; Cleves MA; Yang S; Hobbs CA;
J Pediatr Surg; 2009 Aug; 44(8):1546-51. PubMed ID: 19635303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
